nilvadipine has been researched along with Angina Pectoris, Variant in 1 studies
Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishida, H | 1 |
| Toyama, S | 1 |
| Yanaga, T | 1 |
| Suzuki, K | 1 |
1 trial available for nilvadipine and Angina Pectoris, Variant
| Article | Year |
|---|---|
Effect of a new calcium antagonist, nilvadipine, on variant angina pectoris evaluated by 24-hour Holter electrocardiography.
Topics: Angina Pectoris, Variant; Calcium Channel Blockers; Clinical Trials as Topic; Drug Administration Sc | 1988 |